---
layout: default
title: Multimodal Prototype Alignment for Semi-supervised Pathology Image Segmentation
---

# Multimodal Prototype Alignment for Semi-supervised Pathology Image Segmentation

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2508.19574" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2508.19574v1</a>
  <a href="https://arxiv.org/pdf/2508.19574.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2508.19574v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2508.19574v1', 'Multimodal Prototype Alignment for Semi-supervised Pathology Image Segmentation')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Mingxi Fu, Fanglei Fu, Xitong Ling, Huaitian Yuan, Tian Guan, Yonghong He, Lianghui Zhu

**åˆ†ç±»**: cs.CV, cs.AI

**å‘å¸ƒæ—¥æœŸ**: 2025-08-27

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºMPAMatchä»¥è§£å†³ç—…ç†å›¾åƒåˆ†å‰²ä¸­çš„æ¨¡ç³Šè¾¹ç•Œé—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±äºŒï¼šRLç®—æ³•ä¸æ¶æ„ (RL & Architecture)** **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `ç—…ç†å›¾åƒåˆ†å‰²` `åŠç›‘ç£å­¦ä¹ ` `å¤šæ¨¡æ€å¯¹æ¯”å­¦ä¹ ` `è¯­ä¹‰å»ºæ¨¡` `å›¾åƒå¤„ç†` `æ·±åº¦å­¦ä¹ `

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰æ–¹æ³•ä¸»è¦ä¾èµ–å›¾åƒæ¨¡æ€å†…çš„æ‰°åŠ¨ä¸€è‡´æ€§ï¼Œéš¾ä»¥æ•æ‰å¤æ‚ç—…ç†å›¾åƒçš„é«˜å±‚æ¬¡è¯­ä¹‰ä¿¡æ¯ã€‚
2. MPAMatché€šè¿‡åŒé‡å¯¹æ¯”å­¦ä¹ æ–¹æ¡ˆï¼Œç»“åˆå›¾åƒå’Œæ–‡æœ¬åŸå‹ï¼Œæä¾›ç»“æ„å’Œè¯­ä¹‰å±‚é¢çš„ç›‘ç£ï¼Œæå‡åˆ†å‰²æ•ˆæœã€‚
3. åœ¨GLASã€EBHI-SEG-GLANDã€EBHI-SEG-CANCERå’ŒKPIæ•°æ®é›†ä¸Šçš„å®éªŒç»“æœè¡¨æ˜ï¼ŒMPAMatchåœ¨ç»“æ„å’Œè¯­ä¹‰å»ºæ¨¡æ–¹é¢ä¼˜äºç°æœ‰æœ€å…ˆè¿›æ–¹æ³•ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

ç—…ç†å›¾åƒåˆ†å‰²é¢ä¸´è¯¸å¤šæŒ‘æˆ˜ï¼Œå°¤å…¶æ˜¯æ¨¡ç³Šçš„è¯­ä¹‰è¾¹ç•Œå’Œåƒç´ çº§æ ‡æ³¨çš„é«˜æˆæœ¬ã€‚å°½ç®¡åŸºäºä¸€è‡´æ€§æ­£åˆ™åŒ–çš„åŠç›‘ç£æ–¹æ³•ï¼ˆå¦‚UniMatchï¼‰å–å¾—äº†ä¸€å®šè¿›å±•ï¼Œä½†ä¸»è¦ä¾èµ–äºå›¾åƒæ¨¡æ€å†…çš„æ‰°åŠ¨ä¸€è‡´æ€§ï¼Œéš¾ä»¥æ•æ‰é«˜å±‚æ¬¡çš„è¯­ä¹‰å…ˆéªŒã€‚ä¸ºäº†è§£å†³è¿™äº›å±€é™æ€§ï¼Œæœ¬æ–‡æå‡ºäº†MPAMatchï¼Œä¸€ä¸ªåœ¨å¤šæ¨¡æ€åŸå‹å¼•å¯¼ç›‘ç£èŒƒå¼ä¸‹è¿›è¡Œåƒç´ çº§å¯¹æ¯”å­¦ä¹ çš„æ–°å‹åˆ†å‰²æ¡†æ¶ã€‚MPAMatchçš„æ ¸å¿ƒåˆ›æ–°åœ¨äºå›¾åƒåŸå‹ä¸åƒç´ æ ‡ç­¾ã€æ–‡æœ¬åŸå‹ä¸åƒç´ æ ‡ç­¾ä¹‹é—´çš„åŒé‡å¯¹æ¯”å­¦ä¹ æ–¹æ¡ˆï¼Œæä¾›äº†ç»“æ„å’Œè¯­ä¹‰å±‚é¢çš„ç›‘ç£ã€‚è¯¥æ–¹æ³•æ˜¾è‘—æå‡äº†å¯¹æœªæ ‡è®°æ ·æœ¬çš„åˆ¤åˆ«èƒ½åŠ›ï¼Œå¹¶é¦–æ¬¡å°†æ–‡æœ¬åŸå‹ç›‘ç£å¼•å…¥åˆ†å‰²ï¼Œæ˜¾è‘—æ”¹å–„äº†è¯­ä¹‰è¾¹ç•Œå»ºæ¨¡ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬æ–‡æ—¨åœ¨è§£å†³ç—…ç†å›¾åƒåˆ†å‰²ä¸­çš„æ¨¡ç³Šè¯­ä¹‰è¾¹ç•Œå’Œé«˜æˆæœ¬åƒç´ çº§æ ‡æ³¨çš„é—®é¢˜ã€‚ç°æœ‰çš„åŠç›‘ç£æ–¹æ³•åœ¨æ•æ‰å¤æ‚ç»“æ„çš„é«˜å±‚æ¬¡è¯­ä¹‰å…ˆéªŒæ–¹é¢å­˜åœ¨ä¸è¶³ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šMPAMatchçš„æ ¸å¿ƒæ€è·¯æ˜¯é€šè¿‡å¤šæ¨¡æ€åŸå‹å¼•å¯¼çš„å¯¹æ¯”å­¦ä¹ ï¼Œç»“åˆå›¾åƒå’Œæ–‡æœ¬åŸå‹çš„ç›‘ç£ï¼Œå¢å¼ºæ¨¡å‹å¯¹æœªæ ‡è®°æ ·æœ¬çš„åˆ¤åˆ«èƒ½åŠ›ã€‚è¯¥æ–¹æ³•é¦–æ¬¡å¼•å…¥æ–‡æœ¬åŸå‹ç›‘ç£ï¼Œæå‡äº†è¯­ä¹‰è¾¹ç•Œå»ºæ¨¡çš„æ•ˆæœã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šMPAMatchçš„æ•´ä½“æ¶æ„åŒ…æ‹¬ä¸¤ä¸ªä¸»è¦æ¨¡å—ï¼šå›¾åƒåŸå‹ä¸åƒç´ æ ‡ç­¾ä¹‹é—´çš„å¯¹æ¯”å­¦ä¹ ï¼Œä»¥åŠæ–‡æœ¬åŸå‹ä¸åƒç´ æ ‡ç­¾ä¹‹é—´çš„å¯¹æ¯”å­¦ä¹ ã€‚é€šè¿‡è¿™ä¸¤ä¸ªæ¨¡å—ï¼Œæ¨¡å‹èƒ½å¤Ÿåœ¨ç»“æ„å’Œè¯­ä¹‰å±‚é¢è¿›è¡Œæœ‰æ•ˆçš„å­¦ä¹ ã€‚

**å…³é”®åˆ›æ–°**ï¼šMPAMatchçš„æœ€é‡è¦åˆ›æ–°åœ¨äºå…¶åŒé‡å¯¹æ¯”å­¦ä¹ æ–¹æ¡ˆï¼ŒåŒºåˆ«äºä»¥å¾€æ–¹æ³•ä»…ä¾èµ–å›¾åƒæ¨¡æ€çš„å•ä¸€å¯¹æ¯”å­¦ä¹ ã€‚è¿™ä¸€è®¾è®¡ä½¿å¾—æ¨¡å‹èƒ½å¤ŸåŒæ—¶åˆ©ç”¨ç»“æ„ä¿¡æ¯å’Œè¯­ä¹‰ä¿¡æ¯ï¼Œä»è€Œæ˜¾è‘—æå‡åˆ†å‰²æ€§èƒ½ã€‚

**å…³é”®è®¾è®¡**ï¼šåœ¨ç½‘ç»œç»“æ„ä¸Šï¼ŒMPAMatché‡æ„äº†ç»å…¸çš„TransUNetæ¶æ„ï¼Œé‡‡ç”¨ç—…ç†é¢„è®­ç»ƒçš„åŸºç¡€æ¨¡å‹ï¼ˆUniï¼‰æ›¿ä»£å…¶ViTä¸»å¹²ï¼Œä»¥æ›´æœ‰æ•ˆåœ°æå–ä¸ç—…ç†ç›¸å…³çš„ç‰¹å¾ã€‚åŒæ—¶ï¼ŒæŸå¤±å‡½æ•°è®¾è®¡ä¸Šç»“åˆäº†å¯¹æ¯”æŸå¤±å’Œä¼ ç»Ÿçš„åˆ†å‰²æŸå¤±ï¼Œä»¥å¢å¼ºæ¨¡å‹çš„å­¦ä¹ èƒ½åŠ›ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

åœ¨GLASã€EBHI-SEG-GLANDã€EBHI-SEG-CANCERå’ŒKPIæ•°æ®é›†ä¸Šçš„å®éªŒç»“æœæ˜¾ç¤ºï¼ŒMPAMatchåœ¨ç»“æ„å’Œè¯­ä¹‰å»ºæ¨¡æ–¹é¢æ˜¾è‘—ä¼˜äºç°æœ‰æœ€å…ˆè¿›æ–¹æ³•ï¼Œå…·ä½“æ€§èƒ½æå‡å¹…åº¦è¾¾åˆ°XX%ï¼ˆå…·ä½“æ•°æ®æœªçŸ¥ï¼‰ï¼ŒéªŒè¯äº†å…¶æœ‰æ•ˆæ€§ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶çš„æ½œåœ¨åº”ç”¨é¢†åŸŸåŒ…æ‹¬åŒ»å­¦å½±åƒåˆ†æã€ç—…ç†å­¦ç ”ç©¶å’Œä¸´åºŠè¯Šæ–­ç­‰ã€‚é€šè¿‡æé«˜ç—…ç†å›¾åƒåˆ†å‰²çš„å‡†ç¡®æ€§ï¼ŒMPAMatchæœ‰åŠ©äºåŒ»ç”Ÿåœ¨ç–¾ç—…è¯Šæ–­å’Œæ²»ç–—æ–¹æ¡ˆåˆ¶å®šä¸­çš„å†³ç­–æ”¯æŒï¼Œæœªæ¥å¯èƒ½å¯¹åŒ»ç–—è¡Œä¸šäº§ç”Ÿæ·±è¿œå½±å“ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Pathological image segmentation faces numerous challenges, particularly due to ambiguous semantic boundaries and the high cost of pixel-level annotations. Although recent semi-supervised methods based on consistency regularization (e.g., UniMatch) have made notable progress, they mainly rely on perturbation-based consistency within the image modality, making it difficult to capture high-level semantic priors, especially in structurally complex pathology images. To address these limitations, we propose MPAMatch - a novel segmentation framework that performs pixel-level contrastive learning under a multimodal prototype-guided supervision paradigm. The core innovation of MPAMatch lies in the dual contrastive learning scheme between image prototypes and pixel labels, and between text prototypes and pixel labels, providing supervision at both structural and semantic levels. This coarse-to-fine supervisory strategy not only enhances the discriminative capability on unlabeled samples but also introduces the text prototype supervision into segmentation for the first time, significantly improving semantic boundary modeling. In addition, we reconstruct the classic segmentation architecture (TransUNet) by replacing its ViT backbone with a pathology-pretrained foundation model (Uni), enabling more effective extraction of pathology-relevant features. Extensive experiments on GLAS, EBHI-SEG-GLAND, EBHI-SEG-CANCER, and KPI show MPAMatch's superiority over state-of-the-art methods, validating its dual advantages in structural and semantic modeling.

